Elevai Labs Common Net Income
| ELAB Stock | 1.70 0.01 0.58% |
As of the 12th of February 2026, Elevai Labs shows the Standard Deviation of 8.75, mean deviation of 5.9, and Variance of 76.57. Elevai Labs Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Elevai Labs Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 2.5884 | Revenue | Earnings Share 151.07 |
| Last Reported | Projected for Next Year | ||
| Net Loss | -5.6 M | -5.3 M | |
| Net Loss | -3.6 M | -3.8 M | |
| Net Loss | -1.3 K | -1.3 K | |
| Net Income Per E B T | 1.40 | 1.24 |
Elevai | Net Income | Build AI portfolio with Elevai Stock |
Analyzing Elevai Labs's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Elevai Labs's current valuation and future prospects.
Latest Elevai Labs' Net Income Growth Pattern
Below is the plot of the Net Income of Elevai Labs Common over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Elevai Labs Common financial statement analysis. It represents the amount of money remaining after all of Elevai Labs Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Elevai Labs' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevai Labs' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (6.25 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Elevai Net Income Regression Statistics
| Arithmetic Mean | (1,561,502) | |
| Coefficient Of Variation | (143.72) | |
| Mean Deviation | 1,823,680 | |
| Median | (222,910) | |
| Standard Deviation | 2,244,144 | |
| Sample Variance | 5T | |
| Range | 6M | |
| R-Value | (0.79) | |
| Mean Square Error | 2T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | (351,104) | |
| Total Sum of Squares | 80.6T |
Elevai Net Income History
Other Fundumenentals of Elevai Labs Common
Elevai Labs Net Income component correlations
Elevai Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Elevai Labs is extremely important. It helps to project a fair market value of Elevai Stock properly, considering its historical fundamentals such as Net Income. Since Elevai Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevai Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevai Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs. Projected growth potential of Elevai fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Elevai Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 151.07 | Revenue Per Share | Quarterly Revenue Growth (0.46) | Return On Assets | Return On Equity |
The market value of Elevai Labs Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs' value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs' market value can be influenced by many factors that don't directly affect Elevai Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elevai Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elevai Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elevai Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Elevai Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elevai Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elevai Labs.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Elevai Labs on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Elevai Labs Common or generate 0.0% return on investment in Elevai Labs over 90 days. Elevai Labs is related to or competes with NewcelX, Moolec Science, Dermata Therapeutics, BriaCell Therapeutics, Psyence Biomedical, Virax Biolabs, and XORTX Therapeutics. Elevai Labs is entity of United States. It is traded as Stock on NASDAQ exchange. More
Elevai Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elevai Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elevai Labs Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.39) | |||
| Maximum Drawdown | 53.38 | |||
| Value At Risk | (20.40) | |||
| Potential Upside | 7.4 |
Elevai Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elevai Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elevai Labs' standard deviation. In reality, there are many statistical measures that can use Elevai Labs historical prices to predict the future Elevai Labs' volatility.| Risk Adjusted Performance | (0.29) | |||
| Jensen Alpha | (3.68) | |||
| Total Risk Alpha | (4.38) | |||
| Treynor Ratio | (0.93) |
Elevai Labs February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.29) | |||
| Market Risk Adjusted Performance | (0.92) | |||
| Mean Deviation | 5.9 | |||
| Coefficient Of Variation | (262.06) | |||
| Standard Deviation | 8.75 | |||
| Variance | 76.57 | |||
| Information Ratio | (0.39) | |||
| Jensen Alpha | (3.68) | |||
| Total Risk Alpha | (4.38) | |||
| Treynor Ratio | (0.93) | |||
| Maximum Drawdown | 53.38 | |||
| Value At Risk | (20.40) | |||
| Potential Upside | 7.4 | |||
| Skewness | (1.74) | |||
| Kurtosis | 4.92 |
Elevai Labs Common Backtested Returns
Elevai Labs Common secures Sharpe Ratio (or Efficiency) of -0.4, which denotes the company had a -0.4 % return per unit of risk over the last 3 months. Elevai Labs Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Elevai Labs' Standard Deviation of 8.75, variance of 76.57, and Mean Deviation of 5.9 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.59, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Elevai Labs will likely underperform. At this point, Elevai Labs Common has a negative expected return of -3.64%. Please make sure to confirm Elevai Labs' treynor ratio, kurtosis, and the relationship between the jensen alpha and potential upside , to decide if Elevai Labs Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.78 |
Good predictability
Elevai Labs Common has good predictability. Overlapping area represents the amount of predictability between Elevai Labs time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elevai Labs Common price movement. The serial correlation of 0.78 indicates that around 78.0% of current Elevai Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 2.12 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Elevai Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Elevai Labs Common reported net income of (6.25 Million). This is 101.83% lower than that of the Health Care Equipment & Supplies sector and 108.92% lower than that of the Health Care industry. The net income for all United States stocks is 101.09% higher than that of the company.
Elevai Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevai Labs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevai Labs could also be used in its relative valuation, which is a method of valuing Elevai Labs by comparing valuation metrics of similar companies.Elevai Labs is currently under evaluation in net income category among its peers.
Elevai Fundamentals
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (7.52) % | ||||
| Current Valuation | (2.1 M) | ||||
| Shares Outstanding | 1.19 M | ||||
| Shares Owned By Insiders | 3.34 % | ||||
| Shares Owned By Institutions | 2.52 % | ||||
| Number Of Shares Shorted | 30.68 K | ||||
| Price To Book | 0.23 X | ||||
| Price To Sales | 7.09 X | ||||
| Revenue | 2.47 M | ||||
| Gross Profit | (234.55 K) | ||||
| EBITDA | (3.2 M) | ||||
| Net Income | (6.25 M) | ||||
| Total Debt | 2.33 M | ||||
| Book Value Per Share | 45.64 X | ||||
| Cash Flow From Operations | (5.49 M) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | 151.07 X | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 2.03 M | ||||
| Total Asset | 8.99 M | ||||
| Retained Earnings | (13.27 M) | ||||
| Working Capital | 4.25 M | ||||
| Net Asset | 8.99 M |
About Elevai Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevai Labs Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevai Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevai Labs Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs Common Stock:Check out You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs. Projected growth potential of Elevai fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Elevai Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 151.07 | Revenue Per Share | Quarterly Revenue Growth (0.46) | Return On Assets | Return On Equity |
The market value of Elevai Labs Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs' value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs' market value can be influenced by many factors that don't directly affect Elevai Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elevai Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elevai Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elevai Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.